5 Ulcerative Colitis Clinical Trials in Dothan, AL (2026)

Q: How do I join a clinical trial in Dothan?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Dothan research site will contact you.

Recruiting Ulcerative Colitis Studies in Dothan

NCT07363694Recruiting

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breath...

Dothan, ALPHASE21,156 participantsPfizer

View Study Details

NCT07495852Recruiting

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant...

Dothan, ALPHASE3510 participantsGlaukos Corporation

View Study Details

NCT06588855Recruiting

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

This Phase III, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of induction therapy with Afimkibart (RO7790121) compared with placebo in participants with mo...

Dothan, ALPHASE3350 participantsHoffmann-La Roche

View Study Details

NCT06937086Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disa...

Dothan, ALPHASE3350 participantsEli Lilly and Company

View Study Details

NCT06095128Recruiting

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim...

Dothan, ALPHASE465 participantsTakeda

View Study Details

About Ulcerative Colitis Clinical Trials in Dothan

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 5 ulcerative colitis clinical trials recruiting participants in Dothan, AL. These studies are seeking a combined 2,431 participants. Research is being sponsored by Pfizer, Glaukos Corporation, Hoffmann-La Roche and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Dothan — FAQ

Are there ulcerative colitis clinical trials in Dothan?

Yes, there are 5 ulcerative colitis clinical trials currently recruiting in Dothan, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Dothan?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dothan research site will contact you about next steps.

Are clinical trials in Dothan free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dothan studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 5 active trials in Dothan are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 22, 2026 from ClinicalTrials.gov